Refine
Year of publication
- 2016 (103) (remove)
Document Type
- Preprint (70)
- Article (32)
- Part of Periodical (1)
Language
- English (103)
Has Fulltext
- yes (103)
Is part of the Bibliography
- no (103)
Keywords
- Cardiomyocyte signaling pathways (1)
- Cardioprotection (1)
- Cardiovascular disease (1)
- Centrality Class (1)
- Centrality Selection (1)
- Comorbidities (1)
- Drug targeting (1)
- Endothelial permeability (1)
- Extracellular RNA (eRNA) (1)
- Fissocantharis (1)
Institute
- Frankfurt Institute for Advanced Studies (FIAS) (101)
- Informatik (101)
- Physik (101)
- Hochschulrechenzentrum (1)
- Medizin (1)
Particle identification is an important feature of the ALICE detector at the LHC. In particular, for particle identification via the time-of-flight technique, the precise determination of the event collision time represents an important ingredient of the quality of the measurement. In this paper, the different methods used for such a measurement in ALICE by means of the T0 and the TOF detectors are reviewed. Efficiencies, resolution and the improvement of the particle identification separation power of the methods used are presented for the different LHC colliding systems (pp , p-Pb and Pb-Pb) during the first period of data taking of LHC (Run 1).
Twenty previously known species of Fissocantharis Pic, 1921 and Micropodabrus Pic, 1920 from Taiwan are illustrated and described with the genitalia of both sexes and or abdominal sternite VIII of female. The following reconfirmed combinations are proposed, Micropodabrus chujoi (Wittmer, 1972), M. mucronata (Wittmer, 1979), M. multicostata (Wittmer, 1982) and M. nodicornis (Wittmer, 1982), which were all originally described in Kandyosilis Pic, 1929. Two new species are described, Fissocantharis nigriceps Y. Yang & Okushima sp. nov. and Micropodabrus brunneipennis Y. Yang & Okushima sp. nov., which are provided with the illustrations of aedeagus and photos of male habitus.
In this meeting report, particularly addressing the topic of protection of the cardiovascular system from ischemia/reperfusion injury, highlights are presented that relate to conditioning strategies of the heart with respect to molecular mechanisms and outcome in patients’ cohorts, the influence of co-morbidities and medications, as well as the contribution of innate immune reactions in cardioprotection. Moreover, developmental or systems biology approaches bear great potential in systematically uncovering unexpected components involved in ischemia–reperfusion injury or heart regeneration. Based on the characterization of particular platelet integrins, mitochondrial redox-linked proteins, or lipid-diol compounds in cardiovascular diseases, their targeting by newly developed theranostics and technologies opens new avenues for diagnosis and therapy of myocardial infarction to improve the patients’ outcome.